CANADA LIFE ASSURANCE Co - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5
-54.5%
2,0260.0%0.00%
Q4 2022$11
-99.9%
2,026
-11.0%
0.00%
Q1 2022$18,000
-21.7%
2,2770.0%0.00%
Q4 2021$23,000
-25.8%
2,2770.0%0.00%
Q3 2021$31,000
-38.0%
2,2770.0%0.00%
Q2 2021$50,000
-7.4%
2,2770.0%0.00%
Q1 2021$54,000
+31.7%
2,2770.0%0.00%
Q4 2020$41,000
+57.7%
2,2770.0%0.00%
Q3 2020$26,000
-52.7%
2,2770.0%0.00%
Q2 2020$55,000
+120.0%
2,2770.0%0.00%
Q1 2020$25,000
-58.3%
2,2770.0%0.00%
Q4 2019$60,000
-25.0%
2,277
-12.8%
0.00%
Q2 2019$80,000
+86.0%
2,6120.0%0.00%
Q1 2019$43,000
-10.4%
2,6120.0%0.00%
Q4 2018$48,000
-65.0%
2,6120.0%0.00%
Q3 2018$137,000
+21.2%
2,6120.0%0.00%
Q2 2018$113,000
+189.7%
2,612
+148.3%
0.00%
Q1 2018$39,000
+85.7%
1,0520.0%0.00%
Q4 2017$21,0001,0520.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders